BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23662851)

  • 1. CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage.
    González-Herrero I; Romero-Camarero I; Cañueto J; Cardeñoso-Álvarez E; Fernández-López E; Pérez-Losada J; Sánchez-García I; Román-Curto C
    Br J Dermatol; 2013 Oct; 169(4):830-7. PubMed ID: 23662851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct sets of genetic alterations in melanoma.
    Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
    N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.
    Lee EY; Williamson R; Watt P; Hughes MC; Green AC; Whiteman DC
    Int J Cancer; 2006 Aug; 119(3):636-42. PubMed ID: 16572428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of progenitor cancer stem cell in lentigo maligna melanoma.
    Bongiorno MR; Doukaki S; Malleo F; Aricò M
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S1-5. PubMed ID: 18727808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin.
    Jaimes N; Marghoob AA; Rabinovitz H; Braun RP; Cameron A; Rosendahl C; Canning G; Keir J
    J Am Acad Dermatol; 2015 Jun; 72(6):1027-35. PubMed ID: 25824275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
    Søndergaard K
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
    Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
    Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
    Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
    Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
    Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and analysis of CD133(+) melanoma stem-like cells conferring resistance to taxol: An insight into the mechanisms of their resistance and response.
    El-Khattouti A; Selimovic D; Haïkel Y; Megahed M; Gomez CR; Hassan M
    Cancer Lett; 2014 Feb; 343(1):123-33. PubMed ID: 24080340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomic site, sun exposure, and risk of cutaneous melanoma.
    Whiteman DC; Stickley M; Watt P; Hughes MC; Davis MB; Green AC
    J Clin Oncol; 2006 Jul; 24(19):3172-7. PubMed ID: 16809740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of phenotypic characteristics and exposure to UV radiation in a group of patients with cutaneous melanoma].
    Fagundo E; Rodríguez-García C; Rodríguez C; González S; Sánchez R; Jiménez A
    Actas Dermosifiliogr; 2011 Oct; 102(8):599-604. PubMed ID: 21683319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease.
    Sharma BK; Manglik V; Elias EG
    J Surg Res; 2010 Sep; 163(1):e11-5. PubMed ID: 20638684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there more than one road to melanoma?
    Rivers JK
    Lancet; 2004 Feb; 363(9410):728-30. PubMed ID: 15005091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanomas arising on skin with chronic sun-induced damage exhibit low degree of angiogenesis and lymphangiogenesis.
    Pastushenko I; Vicente-Arregui S; Van den Eynden GG; Gracia-Cazaña T; Carapeto FJ; Alvarez-Alegret R; Dirix LY; Vermeulen PB; Van Laere S
    Am J Dermatopathol; 2015 Jun; 37(6):451-4. PubMed ID: 25747811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological behaviour of cutaneous malignant melanomas.
    Søndergaard K
    Pathology; 1985 Apr; 17(2):255-7. PubMed ID: 4047727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.
    Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA
    Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.